6pjm

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
==HIV-1 Protease NL4-3 WT in Complex with LR2-35==
==HIV-1 Protease NL4-3 WT in Complex with LR2-35==
-
<StructureSection load='6pjm' size='340' side='right'caption='[[6pjm]]' scene=''>
+
<StructureSection load='6pjm' size='340' side='right'caption='[[6pjm]], [[Resolution|resolution]] 1.93&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6PJM OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6PJM FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[6pjm]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6PJM OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6PJM FirstGlance]. <br>
-
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6pjm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6pjm OCA], [http://pdbe.org/6pjm PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6pjm RCSB], [http://www.ebi.ac.uk/pdbsum/6pjm PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6pjm ProSAT]</span></td></tr>
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=OQV:(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl+[(2S,3S,5S)-3-hydroxy-5-{[N-(methoxycarbonyl)-3-methyl-L-valyl]amino}-1,6-diphenylhexan-2-yl]carbamate'>OQV</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
 +
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">pol ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11676 9HIV1])</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6pjm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6pjm OCA], [http://pdbe.org/6pjm PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6pjm RCSB], [http://www.ebi.ac.uk/pdbsum/6pjm PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6pjm ProSAT]</span></td></tr>
</table>
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
The design, synthesis, and X-ray structural analysis of hybrid HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) in a pseudo-C2-symmetric dipeptide isostere are described. A series of PIs were synthesized by incorporating bis-THF of darunavir on either side of the Phe-Phe isostere of lopinavir in combination with hydrophobic amino acids on the opposite P2/P2' position. Structure-activity relationship studies indicated that the bis-THF moiety can be attached at either the P2 or P2' position without significantly affecting potency. However, the group on the opposite P2/P2' position had a dramatic effect on potency depending on the size and shape of the side chain. Cocrystal structures of inhibitors with wild-type HIV-1 protease revealed that the bis-THF moiety retained similar interactions as observed in the darunavir-protease complex regardless of position on the Phe-Phe isostere. Analyses of cocrystal structures and molecular dynamics simulations provide insights for optimizing HIV-1 PIs containing bis-THF in non-sulfonamide dipeptide isosteres.
 +
 +
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-Tetrahydrofuran in a Pseudo-Symmetric Dipeptide Isostere.,Rusere LN, Lockbaum GJ, Henes M, Lee SK, Spielvogel E, Rao DN, Kosovrasti K, Nalivaika EA, Swanstrom R, Kurt Yilmaz N, Schiffer CA, Ali A J Med Chem. 2020 Jul 16. doi: 10.1021/acs.jmedchem.0c00529. PMID:32672965<ref>PMID:32672965</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 6pjm" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Ali A]]
+
[[Category: Ali, A]]
-
[[Category: Henes M]]
+
[[Category: Henes, M]]
-
[[Category: Kosovrasti K]]
+
[[Category: Kosovrasti, K]]
-
[[Category: KurtYilmaz N]]
+
[[Category: KurtYilmaz, N]]
-
[[Category: Lee SK]]
+
[[Category: Lee, S K]]
-
[[Category: Lockbaum GJ]]
+
[[Category: Lockbaum, G J]]
-
[[Category: Nalivaika EA]]
+
[[Category: Nalivaika, E A]]
-
[[Category: Rusere LN]]
+
[[Category: Rusere, L N]]
-
[[Category: Schiffer CA]]
+
[[Category: Schiffer, C A]]
-
[[Category: Spielvogel E]]
+
[[Category: Spielvogel, E]]
-
[[Category: Swanstrom R]]
+
[[Category: Swanstrom, R]]
 +
[[Category: Drug resistance]]
 +
[[Category: Hiv]]
 +
[[Category: Hydrolase]]
 +
[[Category: Hydrolase inhibitor complex]]
 +
[[Category: Hydrolase-hydrolase inhibitor complex]]
 +
[[Category: Nl4-3 protease]]
 +
[[Category: Protease inhibitor]]

Revision as of 11:25, 26 August 2020

HIV-1 Protease NL4-3 WT in Complex with LR2-35

PDB ID 6pjm

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools